News | August 02, 2022
Cadila launches generic sitagliptin versions to treat uncontrolled type 2 diabetes
The two generic drugs have been launched under the brand names Jankey & Sitenali.
The two generic drugs have been launched under the brand names Jankey & Sitenali.
Advancing to IND-enabling studies with multiple drug candidates
This acquisition is in line with Cipla's strategic imperative to augment the company's wellness portfolio for bringing about a shift from an illness to a wellness mindset.
Brings 25 years of global operations and supply chain experience to Piramal
QIAGEN has started its cloud transformation journey with the firm belief that cloud computing can be a key enabler of future business growth
Becomes the first airline globally to develop and launch sustainable, temperature-controlled containers for the transportation of pharmaceuticals
The proposed combination involves corporate restructuring of JVCO, including through acquisition by Haleon via demerger
Report lays out blueprint for achieving Organon’s purpose and business imperatives to help women and girls achieve their promise through better health
The hybrid congress will take place from 1-4 June in Copenhagen, as well as virtually
Pfizer to commercialize NURTEC ODT (rimegepant), an innovative compound for the prevention and acute treatment of migraine, a condition with high unmet need
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
